| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 5.156 | 3.514 | 4.104 | 2.695 | 278 | 354 | 506 | 390 | 2.609 | 0 |
| Total Income - EUR | 5.180 | 3.518 | 4.104 | 2.695 | 278 | 354 | 506 | 390 | 2.609 | 0 |
| Total Expenses - EUR | 3.512 | 3.464 | 3.519 | 2.437 | 897 | 795 | 881 | 549 | 2.296 | 642 |
| Gross Profit/Loss - EUR | 1.668 | 55 | 586 | 258 | -619 | -441 | -375 | -159 | 313 | -642 |
| Net Profit/Loss - EUR | 1.512 | -51 | 462 | 177 | -628 | -452 | -390 | -171 | 264 | -642 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Quantex Medical Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 12.644 | 11.428 | 11.341 | 11.097 | 10.217 | 9.591 | 9.141 | 8.872 | 9.242 | 8.549 |
| Inventories | 5.481 | 4.626 | 3.961 | 3.882 | 3.691 | 3.532 | 3.655 | 3.931 | 5.994 | 5.961 |
| Receivables | 708 | 1.565 | 1.350 | 99 | 7 | 0 | 105 | 135 | 355 | 376 |
| Cash | 6.455 | 5.236 | 6.030 | 7.116 | 6.519 | 6.058 | 5.382 | 4.806 | 2.893 | 2.212 |
| Shareholders Funds | 12.354 | 10.680 | 10.962 | 10.961 | 10.121 | 9.477 | 8.877 | 8.734 | 8.971 | 8.279 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 290 | 748 | 380 | 136 | 96 | 114 | 264 | 138 | 271 | 270 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Quantex Medical Srl